Control of CD56 expression and tumor cell cytotoxicity in human Vγ2Vδ2 T cells
Open Access
- 21 September 2009
- journal article
- Published by Springer Science and Business Media LLC in BMC Immunology
- Vol. 10 (1), 50
- https://doi.org/10.1186/1471-2172-10-50
Abstract
Background In lymphocyte subsets, expression of CD56 (neural cell adhesion molecule-1) correlates with cytotoxic effector activity. For cells bearing the Vγ2Vδ2 T cell receptor, isoprenoid pyrophosphate stimulation leads to uniform activation and proliferation, but only a fraction of cells express CD56 and display potent cytotoxic activity against tumor cells. Our goal was to show whether CD56 expression was regulated stochastically, similar to conventional activation antigens, or whether CD56 defined a lineage of cells committed to the cytotoxic phenotype. Results Tracking individual cell clones defined by their Vγ2 chain CDR3 region sequences, we found that CD56 was expressed on precursor cytotoxic T cells already present in the population irrespective of their capacity to proliferate after antigen stimulation. Public T cell receptor sequences found in the CD56+ subset from one individual might appear in the CD56- subset of another donor. The commitment of individual clones to CD56+ or CD56- lineages was stable for each donor over a 1 year interval. Conclusion The ability to express CD56 was not predicted by TCR sequence or by the strength of signal received by the TCR. For γδ T cells, cytotoxic effector function is acquired when cytotoxic precursors within the population are stimulated to proliferate and express CD56. Expression of CD56 defines a committed lineage to the cytotoxic phenotype.Keywords
This publication has 27 references indexed in Scilit:
- γδ T Cell Selection: Is Anyone Useless?Immunity, 2008
- Isopentenyl Pyrophosphate–Activated CD56+ γδ T Lymphocytes Display Potent Antitumor Activity toward Human Squamous Cell CarcinomaClinical Cancer Research, 2008
- Thymic Selection Determines γδ T Cell Effector Fate: Antigen-Naive Cells Make Interleukin-17 and Antigen-Experienced Cells Make Interferon γImmunity, 2008
- Altered cord blood γδ T cell repertoire in Nigeria: Possible impacts of environmental factors on neonatal immunityMolecular Immunology, 2008
- Lysis of a Broad Range of Epithelial Tumour Cells by Human γδ T Cells: Involvement of NKG2D ligands and T‐cell Receptor‐ versus NKG2D‐dependent RecognitionScandinavian Journal of Immunology, 2007
- Individual Vγ2-Jγ1.2+ T cells respond to both isopentenyl pyrophosphate and Daudi cell stimulation: generating tumor effectors with low molecular weight phosphoantigensCancer Immunology, Immunotherapy, 2006
- Recognition mechanism of non-peptide antigens by human T cellsInternational Immunology, 2003
- KIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive ImmunityAnnual Review of Immunology, 2002
- γδ Cells: A Right Time and a Right Place for a Conserved Third Way of ProtectionAnnual Review of Immunology, 2000
- Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICAScience, 1999